The justices took up the FDA’s appeal after a lower appeals court ruled against the regulatory agency.Read More
Tags :regulation
The products have designs and functions that may attract young people, according to the agency.Read More
The end of 'Chevron deference' doctrine could have ripple effects across the entire nicotine industry in the United States.Read More
While FDA menthol market authorizations are rightly seen as a victory, they may be pyrrhic.Read More
The DEA wants to reclassify it as a less dangerous substance.Read More
While FDA menthol market authorizations are rightly seen as a victory, they may be pyrrhic.Read More
While FDA menthol market authorizations are rightly seen as a victory, they may be pyrrhic.Read More
The requirement will help streamline the reviewing process of ENDS.Read More
The country first classified CBD as a narcotic and banned it in October 2020.Read More
The ruling may make it easier for companies to challenge FDA actions in court. Read More
